Back

Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study

25 August 2023 (11:15 - 11:50)
Organised by: Logo
Congress Presentation Part of: Walking the line between bleeding and thrombosis in valvular heart disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Joonas Lehto

Turku University Hospital, Turku (Finland)

6 More presentations in this session

Presentation thumbnail
Risk of thromboembolic and bleeding events in patients with atrial fibrillation after valvular intervention in either aortic or mitral position
Doctor E. Skogseid (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of protamine administration for prevention of bleeding complications in patients with recent PCI undergoing TAVR
Doctor B. Al-Kassou (Bonn, DE)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes in patients receiving oral anticoagulation stratified by the presence of dose reduction criteria and older age: a subanalysis of ENVISAGE-TAVI AF
Professor N. van Mieghem (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Anticoagulatory treatment and clinical outcomes after transcatheter aortic valve implantation: results from 45,598 patients of the German Aortic Valve Registry (GARY)
Doctor C. Hohmann (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Efficacy of aortic valve replacement on Heyde syndrome-related acquired von Willebrand syndrome and gastrointestinal bleeding: a systematic review and meta-analysis
Mr M. Rooijakkers (Nijmegen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Walking the line between bleeding and thrombosis in valvular heart disease

The Event

Event poster

ESC Congress 2023

25 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Lower dose direct oral anticoagulation and warfarin in atrial fibrillation. Ischemic stroke, intracranial hemorrhage and mortality in a nationwide registry study.
thumbnail
Congress Session
Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations
thumbnail
Congress Presentation
Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources